Improved specificity of in vitro anti-HIV antibody production

Implications for diagnosis and timing of transmission in infants born to HIV- seropositive mothers

X. P. Wang, M. Paul, S. Tetali, E. Abrams, M. Bamji, L. Gulick, N. Chirmule, N. Oyaizu, S. Bakshi, Savita G Pahwa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In vitro anti-HIV antibody production (IVAP), initially introduced as a method for diagnosis of human immunodeficiency virus type 1 (HIV-1) infection in infants, has been limited in its application because of poor specificity and sensitivity early in life. The aims of this study were to improve the specificity of the IVAP assay and to evaluate its sensitivity in conjunction with assays of HIV culture, polymerase chain reaction (PCR), and p24 antigen. To prevent false-positive reactions resulting from maternal serum-derived cytophilic anti-HIV IgG, additional preculture and washing steps for peripheral blood mononuclear cells (PBMCs) were introduced that resulted in dramatic improvement in specificity of IVAP. The sensitivity of the revised IVAP at age <3 months in 20 infected infants was, however, only 25%; of 15 infected infants initially negative in IVAP, 13 became positive at a mean estimated age of 4.4±1.8 months. When correlated with virological assays, a failure to respond in IVAP at age <1 month was often associated with negative virological identification, whereas a positive IVAP response at age <3 months was always associated with positive results in all virological assays. Moreover, conversion from negative IVAP to positive responses occurred subsequent to, and not concurrently with, a positive virological identification of infected infants. The revised IVAP methodology renders this assay potentially useful as an additional tool not only for the diagnosis of HIV infection, but for estimating timing of maternal-infant HIV transmission as well.

Original languageEnglish
Pages (from-to)691-699
Number of pages9
JournalAIDS Research and Human Retroviruses
Volume10
Issue number6
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

HIV Antibodies
Antibody Formation
Anti-Idiotypic Antibodies
Mothers
HIV
In Vitro Techniques
False Positive Reactions
Virus Diseases
HIV Infections
HIV-1
Blood Cells
Antigens
Sensitivity and Specificity
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Improved specificity of in vitro anti-HIV antibody production : Implications for diagnosis and timing of transmission in infants born to HIV- seropositive mothers. / Wang, X. P.; Paul, M.; Tetali, S.; Abrams, E.; Bamji, M.; Gulick, L.; Chirmule, N.; Oyaizu, N.; Bakshi, S.; Pahwa, Savita G.

In: AIDS Research and Human Retroviruses, Vol. 10, No. 6, 01.01.1994, p. 691-699.

Research output: Contribution to journalArticle

Wang, X. P. ; Paul, M. ; Tetali, S. ; Abrams, E. ; Bamji, M. ; Gulick, L. ; Chirmule, N. ; Oyaizu, N. ; Bakshi, S. ; Pahwa, Savita G. / Improved specificity of in vitro anti-HIV antibody production : Implications for diagnosis and timing of transmission in infants born to HIV- seropositive mothers. In: AIDS Research and Human Retroviruses. 1994 ; Vol. 10, No. 6. pp. 691-699.
@article{0eee2562901a4201aa8b3cbebf6f4f4f,
title = "Improved specificity of in vitro anti-HIV antibody production: Implications for diagnosis and timing of transmission in infants born to HIV- seropositive mothers",
abstract = "In vitro anti-HIV antibody production (IVAP), initially introduced as a method for diagnosis of human immunodeficiency virus type 1 (HIV-1) infection in infants, has been limited in its application because of poor specificity and sensitivity early in life. The aims of this study were to improve the specificity of the IVAP assay and to evaluate its sensitivity in conjunction with assays of HIV culture, polymerase chain reaction (PCR), and p24 antigen. To prevent false-positive reactions resulting from maternal serum-derived cytophilic anti-HIV IgG, additional preculture and washing steps for peripheral blood mononuclear cells (PBMCs) were introduced that resulted in dramatic improvement in specificity of IVAP. The sensitivity of the revised IVAP at age <3 months in 20 infected infants was, however, only 25{\%}; of 15 infected infants initially negative in IVAP, 13 became positive at a mean estimated age of 4.4±1.8 months. When correlated with virological assays, a failure to respond in IVAP at age <1 month was often associated with negative virological identification, whereas a positive IVAP response at age <3 months was always associated with positive results in all virological assays. Moreover, conversion from negative IVAP to positive responses occurred subsequent to, and not concurrently with, a positive virological identification of infected infants. The revised IVAP methodology renders this assay potentially useful as an additional tool not only for the diagnosis of HIV infection, but for estimating timing of maternal-infant HIV transmission as well.",
author = "Wang, {X. P.} and M. Paul and S. Tetali and E. Abrams and M. Bamji and L. Gulick and N. Chirmule and N. Oyaizu and S. Bakshi and Pahwa, {Savita G}",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "10",
pages = "691--699",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Improved specificity of in vitro anti-HIV antibody production

T2 - Implications for diagnosis and timing of transmission in infants born to HIV- seropositive mothers

AU - Wang, X. P.

AU - Paul, M.

AU - Tetali, S.

AU - Abrams, E.

AU - Bamji, M.

AU - Gulick, L.

AU - Chirmule, N.

AU - Oyaizu, N.

AU - Bakshi, S.

AU - Pahwa, Savita G

PY - 1994/1/1

Y1 - 1994/1/1

N2 - In vitro anti-HIV antibody production (IVAP), initially introduced as a method for diagnosis of human immunodeficiency virus type 1 (HIV-1) infection in infants, has been limited in its application because of poor specificity and sensitivity early in life. The aims of this study were to improve the specificity of the IVAP assay and to evaluate its sensitivity in conjunction with assays of HIV culture, polymerase chain reaction (PCR), and p24 antigen. To prevent false-positive reactions resulting from maternal serum-derived cytophilic anti-HIV IgG, additional preculture and washing steps for peripheral blood mononuclear cells (PBMCs) were introduced that resulted in dramatic improvement in specificity of IVAP. The sensitivity of the revised IVAP at age <3 months in 20 infected infants was, however, only 25%; of 15 infected infants initially negative in IVAP, 13 became positive at a mean estimated age of 4.4±1.8 months. When correlated with virological assays, a failure to respond in IVAP at age <1 month was often associated with negative virological identification, whereas a positive IVAP response at age <3 months was always associated with positive results in all virological assays. Moreover, conversion from negative IVAP to positive responses occurred subsequent to, and not concurrently with, a positive virological identification of infected infants. The revised IVAP methodology renders this assay potentially useful as an additional tool not only for the diagnosis of HIV infection, but for estimating timing of maternal-infant HIV transmission as well.

AB - In vitro anti-HIV antibody production (IVAP), initially introduced as a method for diagnosis of human immunodeficiency virus type 1 (HIV-1) infection in infants, has been limited in its application because of poor specificity and sensitivity early in life. The aims of this study were to improve the specificity of the IVAP assay and to evaluate its sensitivity in conjunction with assays of HIV culture, polymerase chain reaction (PCR), and p24 antigen. To prevent false-positive reactions resulting from maternal serum-derived cytophilic anti-HIV IgG, additional preculture and washing steps for peripheral blood mononuclear cells (PBMCs) were introduced that resulted in dramatic improvement in specificity of IVAP. The sensitivity of the revised IVAP at age <3 months in 20 infected infants was, however, only 25%; of 15 infected infants initially negative in IVAP, 13 became positive at a mean estimated age of 4.4±1.8 months. When correlated with virological assays, a failure to respond in IVAP at age <1 month was often associated with negative virological identification, whereas a positive IVAP response at age <3 months was always associated with positive results in all virological assays. Moreover, conversion from negative IVAP to positive responses occurred subsequent to, and not concurrently with, a positive virological identification of infected infants. The revised IVAP methodology renders this assay potentially useful as an additional tool not only for the diagnosis of HIV infection, but for estimating timing of maternal-infant HIV transmission as well.

UR - http://www.scopus.com/inward/record.url?scp=0028118083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028118083&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 691

EP - 699

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 6

ER -